These are rare types of tumors that start in the cells that make up the sex cords or the outer covering of the gonads (testes or ovaries). Think of the gonads as the main reproductive organs. These tumors can develop in either the testes or the ovaries. They are sometimes called sex cord-stromal tumors.
Every report comes from a Lived member, sent anonymously.
Have you had Salpingo-oophorectomy for Sex Cord-Gonadal Stromal Tumors?
Sex cord-gonadal stromal tumors are a family of uncommon growths that start in the supporting, hormone-making tissue of an ovary or testicle. They do not start in the cells that become eggs or sperm (germ cell tumors), or in the surface lining where most ovarian cancers begin. Some are benign, some are cancers, and many fall in between: they usually grow slowly but can come back. Because they grow from tissue that normally makes sex hormones, many of these tumors make hormones too, and that is often how they come to attention. Tumors that make estrogen can cause irregular or heavy periods, bleeding after menopause, or early puberty in a young child. Tumors that make androgens (male-type hormones such as testosterone) can cause periods to stop, acne, extra facial or body hair, or a deepening voice. Others cause no hormone effects and show up as a swollen belly, pelvic pain or a mass found on a scan. The name covers several distinct tumors. In the ovary, the main ones are granulosa cell tumors (the most common type that can be cancerous), Sertoli-Leydig cell tumors, and fibromas and thecomas, which are usually benign. Granulosa cell tumors come in an adult type, usually found around ages 50 to 55, and a juvenile type that mostly affects children and teenagers. In the testicle, the main types are Leydig cell and Sertoli cell tumors. They make up less than 5% of adult testicular tumors but up to about 20% in children, and most are not cancer. The exact type matters, because it shapes treatment and follow-up.
For most people, no cause or trigger is found, and nothing a person did is known to bring these tumors on. Inherited genetics matter for some types. Ovarian Sertoli-Leydig cell tumors in children and young women are often linked to an inherited change in a gene called DICER1. In one large registry, more than half of the people tested carried such a variant. DICER1 changes also raise the risk of other tumors, including thyroid nodules and a rare childhood lung cancer, so anyone with a Sertoli-Leydig cell tumor should be offered genetic testing and counseling, and relatives may benefit too. Less often, Sertoli-Leydig tumors occur with Peutz-Jeghers syndrome, an inherited condition that causes polyps in the gut. Juvenile granulosa cell tumors have been reported in children with Ollier disease and Maffucci syndrome, rare conditions that affect bone and cartilage. Adult granulosa cell tumors are generally not inherited.
These tumors usually come to light because of a mass, pain or hormone changes. An ultrasound is typically the first test, and MRI (magnetic resonance imaging) can help show whether a mass looks like this kind of tumor and how it relates to nearby organs. A testicular mass is examined first with an ultrasound of the scrotum. Blood tests help. For ovarian tumors, inhibin A and B (hormones made by granulosa cells) are often high, and estrogen or testosterone levels may point to a hormone-making tumor. These markers support a diagnosis but cannot confirm it, and they are useful later for spotting a return. CA-125, the marker often discussed for ovarian cancer, is more typical of the common surface (epithelial) cancers. A firm diagnosis comes only from examining the tumor under a microscope after it is removed, ideally by a pathologist experienced with these rare tumors. Surgery also stages the tumor, showing whether it stayed within the ovary or testicle. When a granulosa cell tumor has been making estrogen, the lining of the uterus is usually checked as well, because extra estrogen can thicken it (endometrial hyperplasia) and is sometimes linked with endometrial cancer.
Surgery to remove the whole tumor is the main treatment for every type. Surgeons aim to take it out in one piece, because a tumor that ruptures or spills during surgery is more likely to come back. For ovarian tumors, the extent of surgery depends on age, stage and plans for pregnancy. Many children, teenagers and younger adults with an early-stage tumor can have fertility-sparing surgery, which removes only the affected ovary and fallopian tube and keeps the uterus and other ovary. Studies of this approach report good survival, and many people go on to have regular periods and pregnancies. After menopause, or when the tumor has spread, the usual operation removes the uterus and both ovaries. Chemotherapy is not needed for most early tumors. It is generally considered when the tumor has spread, ruptured, or looks aggressive under the microscope, and it is usually a platinum-based combination built around cisplatin. Most of the evidence comes from registries rather than clinical trials. For adult granulosa cell tumors, studies have not clearly shown that chemotherapy after surgery prevents a return. Testicular Leydig and Sertoli cell tumors are usually treated by removing the affected testicle through the groin (radical inguinal orchiectomy). For selected small tumors, surgeons may remove only the tumor and keep the testicle, although the tumor occasionally returns in that testicle. If the tumor appears to have spread, lymph nodes at the back of the abdomen may be removed. Chemotherapy and radiation generally work poorly for these testicular tumors, which is why surgery is central.
Most people are diagnosed while the tumor is still confined to the ovary or testicle, and the outlook is generally good. Benign tumors such as fibromas are usually cured by surgery. Juvenile granulosa cell tumors and early Sertoli-Leydig tumors are usually cured by surgery alone, and most testicular stromal tumors never spread. Follow-up is a major part of life afterward, and its length depends on the type. Adult granulosa cell tumors are known for coming back late, sometimes more than 20 years after surgery, so follow-up usually continues for many years with exams, blood markers such as inhibin, and imaging when needed. People with a DICER1 variant may need monitoring for a new tumor in the other ovary, and for thyroid and other related conditions. After testicular surgery, experts recommend follow-up with periodic scans, tailored to the tumor type. Advanced or recurrent tumors are harder to treat and carry a less certain outlook. Because these tumors are rare, care at a center with experience in them, and enrolling in a registry, can help.
Arrange a medical visit for vaginal bleeding after menopause, periods that become very irregular or stop without explanation, new facial or body hair, acne or voice deepening, ongoing bloating or a feeling of fullness in the pelvis, a lump or swelling in a testicle, or unexplained breast growth in a man or boy. Signs of puberty in a young child also need prompt evaluation. Sudden, severe belly or pelvic pain in someone with a known or suspected ovarian mass needs medical help right away, because the tumor can twist, bleed or rupture. After treatment, contact your care team about new pelvic or belly symptoms, a return of hormone-related changes, or rising markers, even many years later.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Sex Cord-Gonadal Stromal Tumors is like, what's helped you, or ask the community a question.